The New York Times - Business:

The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy.

This post first appeared in The New York Times - Business. Read the original article.